SCHEMBL3511620

SCHEMBL3511620

O=C(O)Cc1cccc(Oc2cccc(OCC=Cc3ccc(C(F)(F)F)cc3)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.46
LTB4R2 Q9NPC1 1/20 0.46
PPARG P37231 4/20 0.46
PSEN1 P49768 2/20 0.46
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
PPARD Q03181 5/20 0.45
EPOR P19235 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PPARA Q07869 4/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
S1PR5 Q9H228 2/20 0.41
MRGPRX4 Q96LA9 2/20 0.41
MAOB P27338 1/20 0.40
NR4A2 P43354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3508860 1.00 LTB4R (0.46) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3507303 0.95 LTB4R (0.46) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3507297 0.95 LTB4R (0.46) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3508522 0.93 PPARG (0.49) PPARGPSEN1PTGESALOX5PPARD
SCHEMBL3508526 0.93 PPARG (0.49) PPARGPSEN1PTGESALOX5PPARD
SCHEMBL3506356 0.91 PPARG (0.45) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3506351 0.91 PPARG (0.45) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL14051593 0.91 PPARG (0.45) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3508438 0.90 PPARG (0.44) LTB4RLTB4R2PPARGPSEN1PTGES
SCHEMBL3508435 0.90 PPARG (0.44) LTB4RLTB4R2PPARGPSEN1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use PPARG, PPARD, PPARA LTB4R 634/4885LTB4R2 614/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.